News

Danish drugmaker Novo Nordisk is teaming up with California-based biotech Septerna to develop new pills to treat obesity, ...
Investors may get a second bite at the apple, and a second chance to buy this GLP-1 drug leader at a discount price.
Discussions between Novo Nordisk and the Novo Nordisk Foundation that controls the company regarding a CEO change have been ...
Novo Nordisk A/S is replacing Chief Executive Officer Lars Fruergaard Jorgensen as the drugmaker wrestles with increased ...